Imetelstat (1) – Rytelo®
Myelodysplastic syndromes with transfusion-dependent anaemia, previously treated
Characteristics
| Start date | 15.11.2026 |
|---|---|
| Resolution | 05.05.2027 – active procedure |
| INN | Imetelstat |
| Brand name | Rytelo® |
| Pharm. company | Geron Netherlands B.V. |
| G-BA Procedure ID | D-1406 |
| Therapeutic area | Hematopoietic diseases Orphan |
| Reason for procedure | Initial assessment |
Associated procedures
<< List of all resolutions